Filtered By:
Drug: Amphetamine
This page shows you your search results in order of date.
Order by Relevance | Date
Total 49 results found since Jan 2013.
Why the Adderall Shortage Has Lasted So Long
In October 2022, the U.S. Food and Drug Administration (FDA) announced a shortage of amphetamine mixed salts—a drug category that includes Adderall, the stimulant medication often used to treat attention-deficit/hyperactivity disorder (ADHD).
In the six months since, little has changed. Numerous amphetamine mixed salts products are still in short supply, although certain manufacturers expect to release additional inventory in April or May, according to an Apr. 10 update to the American Society of Health-System Pharmacists’ (ASHP) drug shortage database.
Half a year may seem like ample time to get more of a medi...
Source: TIME: Health - April 18, 2023 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Drugs healthscienceclimate Source Type: news
Pre-Workout Powders Are Gaining Popularity. Do They Work?
If you’ve trained your social-media algorithms to serve you even a little bit of fitness content, scrolling your TikTok feed might feel like wandering the aisles of a vitamin store. Workout vlogs often feature a prominently displayed tub of something called pre-workout powder: Just mix a scoop into a glass of water, down it before exercising, and you’ll instantly become more efficient and energized during your workout.
That’s the hoped-for benefit, anyway. The reality is more of a gamble.
“Pre-workout,” a packaged powder that contains at least a dozen supplements—and usually more—...
Source: TIME: Health - April 7, 2023 Category: Consumer Health News Authors: Haley Weiss Tags: Uncategorized Diet & Nutrition healthscienceclimate Source Type: news
ADHD Medication Might Help In Treating Amphetamine Addiction
A recent JAMA Psychiatry study found that an ADHD medicine called lisdexamfetamine reduced the risk of hospitalization due to amphetamine or methamphetamine addiciton by 18% and 14% for deaths caused by substance abuse disorders.
Source: Forbes.com Healthcare News - November 25, 2022 Category: Pharmaceuticals Authors: Anuradha Varanasi, Contributor Tags: Healthcare /healthcare Innovation /innovation Source Type: news
Caroline Ellison, one of the central figures behind FTX ' s collapse, previously tweeted that regularly using amphetamines made the ' non-medicated ' life seem …
FTX-linked Caroline Ellison's past tweets about 'regular amphetamine use' have resurfaced online. Ellison is the CEO of Alameda Research, the hedge fund FTX reportedly used to borrow money for bets. Amphetamines are often prescribed to treat ADHD. Old drug-related tweets posted by Caroline Ellison…#carolineellison #ellison #ftx #alameda #ftxlinkedcaroline #regularamphetamine #caroline #ftxgrouplinked #bankmanfried #adhd
Source: Reuters: Health - November 19, 2022 Category: Consumer Health News Source Type: news
FTX-linked Caroline Ellison ' s amphetamine tweets have resurfaced
FTX-linked Caroline Ellison's past tweets about 'regular amphetamine use' have resurfaced online. - Ellison is the CEO of Alameda Research, the hedge fund FTX reportedly used to borrow money for bets. - Amphetamines are often prescribed to treat ADHD. Old drug-related tweets posted by Caroline…#ellison #carolineellison #ftx #alameda #ftxlinkedcaroline #caroline #regularamphetamine #ftxgrouplinked #amphetamines #bankmanfried
Source: Reuters: Health - November 19, 2022 Category: Consumer Health News Source Type: news
What's With the National Adderall Shortage?
(MedPage Today) -- Patients who rely on medication to treat their attention deficit-hyperactivity disorder (ADHD) are struggling to fill their prescriptions because of a national shortage of amphetamine/dextroamphetamine (Adderall).
On Reddit...
Source: MedPage Today Public Health - October 19, 2022 Category: American Health Source Type: news
Vallon Pharmaceuticals stock plunges 70% after ADHD drug candidate misses primary endpoint
Vallon Pharmaceuticals' stock plunged by more than 70% Monday after the Philadelphia biopharmaceutical company announced disappointing clinical trial results for its experimental treatment of attention deficit hyperactivity disorder.
The company's new drug candidate, ADAIR — an acronym for Abuse Deterrent Amphetamine Immediate Release — is a proprietary abuse-deterrent formulation of dextroamphetamine for the treatment of ADHD. Dextroamphetamine has been used clinically for more than 50 years.…
Source: bizjournals.com Health Care:Physician Practices headlines - March 21, 2022 Category: American Health Authors: John George Source Type: news
Tris Pharma Announces FDA Approval of Dyanavel XR (amphetamine) Once-Daily Extended-Release Oral Tablets, CII, for ADHD
In a clinical study in adults, Dyanavel XR tablets demonstrated bioequivalence to Dyanavel XR (amphetamine) extended-release oral suspension.
ADHD patients taking Dyanavel XR oral suspension can conveniently switch to the same dose of Dyanavel XR...
Source: Drugs.com - New Drug Approvals - November 5, 2021 Category: Drugs & Pharmacology Source Type: news
Amphetamines and the privilege of being spared from sanction in road traffic due to medication - Mu ßhoff F, Skopp G, Madea B, Maas A.
On the one hand, amphetamine (racemic D,L-amphetamine, ratio 1:1) is used as an illegal drug; but on the other hand, especially D-amphetamine serves to treat narcolepsy and preferentially activity deficiency/ hyperactivity disorder (ADHD). Recently, in Ger...
Source: SafetyLit - September 15, 2021 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
Arbor Pharmaceuticals Announces FDA Filing Acceptance of New Drug Application (NDA) for AR19, an Investigational ADHD Prescription Stimulant Treatment Specifically Designed to Resist Physical Manipulation for Nonmedical Misuse or Abuse
If approved, AR19 would be the first-ever FDA-approved ADHD stimulant medication designed to resist manipulation for nonmedical use, which may help to deter misuse and abuse by intranasal, intravenous and smoking routes of administration
ATLANTA, May 13... Biopharmaceuticals, FDA Arbor Pharmaceuticals, amphetamine, ADHD
Source: HSMN NewsFeed - May 13, 2020 Category: Pharmaceuticals Source Type: news
Medical News Today: What is the link between Vyvanse and hypersexuality?
Vyvanse is a brand of amphetamine that doctors may prescribe for ADHD or binge eating disorder (BED). Some research links amphetamine use to hypersexuality, and both ADHD and BED may also affect sexual function. Learn more about the symptoms of hypersexuality and the effects of the drug here.
Source: Health News from Medical News Today - June 27, 2019 Category: Consumer Health News Tags: Sexual Health / STDs Source Type: news
FDA Approves First Medical Device To Treat ADHD In Children
(CNN) — The first medical device to treat childhood attention deficit hyperactivity disorder, or ADHD, was OK’d Friday by the US Food and Drug Administration. Designated for children ages 7 to 12 who are not currently on medication for the disorder, the device delivers a low-level electrical pulse to the parts of the brain responsible for ADHD symptoms.
“This new device offers a safe, non-drug option for treatment of ADHD in pediatric patients through the use of mild nerve stimulation, a first of its kind,” Carlos Peña, director of the Division of Neurological and Physical Medicine Devices in the F...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - April 22, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News CNN ADHD Source Type: news
In Youth With ADHD, New-Onset Psychosis Up With Amphetamines
THURSDAY, March 21, 2019 -- For adolescents and young adults with attention-deficit/hyperactivity disorder (ADHD), new-onset psychosis occurs more often with amphetamine use versus methylphenidate use, according to a study published in the March 21...
Source: Drugs.com - Pharma News - March 21, 2019 Category: Pharmaceuticals Source Type: news
With ADHD, amphetamine has double the psychosis risk of methylphenidate
(Reuters Health) - Children and young adults with attention deficit-hyperactivity disorder (ADHD) who are treated with the stimulants amphetamine or methylphenidate face a small but significant risk of developing psychosis, with amphetamine products twice as likely to spark at problem, researchers say.
Source: Reuters: Health - March 20, 2019 Category: Consumer Health News Tags: healthNews Source Type: news
Medical News Today: What is Evekeo?
Evekeo is an amphetamine-based medication that is used to treat narcolepsy, ADHD, and excess weight. Evekeo is the trade name as there is no generic amphetamine drug. It is a controlled substance, due to the risk of dependence and adverse effects. Find out more about this drug, its uses, and the risks involved.
Source: Health News from Medical News Today - June 20, 2018 Category: Consumer Health News Tags: Pharmacy / Pharmacist Source Type: news
